Literature DB >> 26663793

Diagnostic Yield of Routine Enteropathogenic Stool Tests in Pediatric Ulcerative Colitis.

Faith D Ihekweazu1, Avanthi Ajjarapu2, Richard Kellermayer2.   

Abstract

GOALS: It can be important to exclude infectious etiologies prior to adjusting immunosuppressive therapy in patients with ulcerative colitis (UC) exacerbation. We sought to determine the diagnostic yield of routine infectious stool studies in pediatric UC patients. PROCEDURES: We conducted a retrospective review of 152 pediatric UC patients at Texas Children's Hospital between January 2003 and December 2009. The patient records were followed through July 2014. The number and type of infectious stool studies performed and the results of those were collected.
RESULTS: Three hundred fifty-four diagnostic stool tests were conducted for Clostridium difficile; 13.6% were positive. Two hundred twenty stool bacterial cultures were performed, and 1.8% were positive, all growing non-typhoid Salmonella. One of 13 (7.7%) Adenovirus PCR tests was positive. Two of 152 examinations (1.3%) for Ova and Parasites were positive. No stool tests for viral culture, viral particles, Yersinia or Rotavirus were positive.
CONCLUSIONS: Clostridium difficile infection is common in pediatric UC, and routine screening during flares is strongly recommended. Other bacterial and parasitic infections routinely tested for are uncommon, but Salmonella may be a potentially important attribute to disease exacerbations in select patients. In patients without co-morbid conditions, the utility of performing non-specific fecal viral tests is questionable.
© 2015 by the Association of Clinical Scientists, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 26663793      PMCID: PMC5358327     

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  18 in total

1.  Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: prevalence and risk factors.

Authors:  Aleksandra Banaszkiewicz; Kinga Kowalska-Duplaga; Tomasz Pytrus; Hanna Pituch; Andrzej Radzikowski
Journal:  Inflamm Bowel Dis       Date:  2011-09-20       Impact factor: 5.325

2.  Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

Authors:  J F Rahier; F Magro; C Abreu; A Armuzzi; S Ben-Horin; Y Chowers; M Cottone; L de Ridder; G Doherty; R Ehehalt; M Esteve; K Katsanos; C W Lees; E Macmahon; T Moreels; W Reinisch; H Tilg; L Tremblay; G Veereman-Wauters; N Viget; Y Yazdanpanah; R Eliakim; J F Colombel
Journal:  J Crohns Colitis       Date:  2014-03-06       Impact factor: 9.071

3.  Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease.

Authors:  Tine Jess; Jacob Simonsen; Nete Munk Nielsen; Kristian Tore Jørgensen; Peter Bager; Steen Ethelberg; Morten Frisch
Journal:  Gut       Date:  2010-12-29       Impact factor: 23.059

4.  Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool.

Authors:  Maria Mylonaki; Louise Langmead; Athanasios Pantes; Frith Johnson; David S Rampton
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-08       Impact factor: 2.566

Review 5.  Infections and inflammatory bowel disease: challenges in Asia.

Authors:  Siew C Ng; Francis Kl Chan
Journal:  J Dig Dis       Date:  2013-11       Impact factor: 2.325

Review 6.  Clostridium difficile and inflammatory bowel disease.

Authors:  Mazen Issa; Ashwin N Ananthakrishnan; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

7.  Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.

Authors:  Kim O Gradel; Hans L Nielsen; Henrik C Schønheyder; Tove Ejlertsen; Brian Kristensen; Henrik Nielsen
Journal:  Gastroenterology       Date:  2009-04-08       Impact factor: 22.682

8.  Seasonal variation of enteric infections and inflammatory bowel disease.

Authors:  Amnon Sonnenberg
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

9.  Clostridium difficile infection in newly diagnosed pediatric inflammatory bowel disease in the mid-southern United States.

Authors:  Sabina A V Mir; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-10       Impact factor: 2.839

10.  Blastocystis: Consensus of treatment and controversies.

Authors:  Uma Sekar; M Shanthi
Journal:  Trop Parasitol       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.